Clinical Trial Update: Trial of Panitumumab/Cisplatin/Fluorouracil Combined With Radiation in Esophageal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating panitumumab with cisplatin, fluorouracil, and radiation for esophageal cancer was terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• FLUOROURACIL (Fluorouracil)
• Panitumumab (panitumumab)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-01-23